| 英文名称 |
中文名称 |
CAS号 |
操作 |
| PPC-NB |
|
1887040-81-4 |
详细
|
| Mal-Phe-C4-VC-PAB-MMAE |
|
2259318-51-7 |
详细
|
| MC-VC-PABC-DNA31 |
|
1639352-03-6 |
详细
|
| Vc-seco-DUBA |
|
1345681-58-4 |
详细
|
| Deruxtecan analog 2 |
化合物 DERUXTECAN ANALOG 2 |
1599440-10-4 |
详细
|
| Phe-Lys(Fmoc)-PAB |
|
2149584-03-0 |
详细
|
| Azido-PEG5-CH2CO2H |
叠氮-五聚乙二醇-乙酸 |
217180-81-9 |
详细
|
| Maleimido-tri(ethylene glycol)-propionic acid |
马来酰亚胺-三聚乙二醇-丙酸 |
518044-40-1 |
详细
|
| N-(5-Hydroxypentyl)maleimide |
1H-Pyrrole-2,5-dione, 1-(5-hydroxypentyl) |
180608-78-0 |
详细
|
| Nitenpyram |
烯啶虫胺 |
150824-47-8 |
详细
|
| Dxd |
DX-8951衍生物 |
1599440-33-1 |
详细
|
| MMAF hydrochloride |
MONOMETHYLAURISTATIN F HYDROCHLORIDE |
1415246-68-2 |
详细
|
| Fmoc-Gly-Gly-Phe-OH |
|
160036-44-2 |
详细
|
| MMAF sodium |
|
1799706-65-2 |
详细
|
| Auristatin E |
澳瑞他汀E |
160800-57-7 |
详细
|
| Taltobulin trifluoroacetate |
228266-41-9 |
228266-41-9 |
详细
|
| Mertansine |
美登素 |
139504-50-0 |
详细
|
| INX-SM-56 |
化合物 INX-SM-56 |
2734878-18-1 |
详细
|
| MC-Val-Ala-OH |
N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-L-alanine |
1342211-31-7 |
详细
|
| SPDB |
|
115088-06-7 |
详细
|
| CL2-SN-38 |
CL2-SN38 |
1036969-20-6 |
详细
|
| Mal-PEG4-NHS ester |
马来酰亚胺-四聚乙二醇-丙烯酸琥珀酰亚胺酯 |
1325208-25-0 |
详细
|
| PNU-120596 |
PNU 120596 |
501925-31-1 |
详细
|
| SuO-Glu-Val-Cit-PAB-MMAE |
|
1895916-24-1 |
详细
|
| Gly3-VC-PAB-MMAE |
|
2684216-48-4 |
详细
|
| PROTAC BRD4 Degrader-10 |
|
2417370-49-9 |
详细
|
| Val-cit-PAB-OH |
VAL-CIT-PAB |
159857-79-1 |
详细
|
| Mal-amido-PEG1-C2-NHS ester |
MAL-AMIDO-PEG1-C2-?NHS ESTER |
1260092-50-9 |
详细
|
| Propargyl-C1-NHS ester |
4-戊炔酸琥珀亚胺酯 |
132178-37-1 |
详细
|
| Mal-PEG1-acid |
|
760952-64-5 |
详细
|
| Auristatin F |
澳瑞他汀 F |
163768-50-1 |
详细
|
| N3-Ph-NHS ester |
琥珀酰亚胺基 4-叠氮基苯甲酸酯 |
53053-08-0 |
详细
|
| Mal-VC-PAB-DM1 |
|
1464051-44-2 |
详细
|
| MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT |
|
2378428-19-2 |
详细
|
| Mal-C2-NHS ester |
5-马来酰亚胺戊酸NHS |
103750-03-4 |
详细
|
| (2-pyridyldithio)-PEG1-hydrazine |
2-[2-(吡啶基)连硫基]乙醇 |
111625-28-6 |
详细
|
| DBM-MMAF |
|
1810001-93-4 |
详细
|
| DBCO-PEG4-VC-PAB-MMAE |
二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-MMAE |
2129164-91-4 |
详细
|
| MC-betaglucuronide-MMAE-1 |
|
1703778-92-0 |
详细
|
| MC-VA-PABC-MMAE |
化合物 MC-VA-PABC-MMAE |
1818864-51-5 |
详细
|
| Indole-C2-amide-C2-NH2 |
化合物 INDOLE-C2-AMIDE-C2-NH2 |
215789-29-0 |
详细
|
| OH-Glu-Val-Cit-PAB-MMAE |
|
1895916-23-0 |
详细
|
| 11-Azidoundecanoic acid |
11-叠氮十一酸,11-AZIDO-UNDECANOIC ACID |
118162-45-1 |
详细
|
| alpha-GalNAc-TEG-N3 |
Α-GALNAC-PEG3-叠氮化物 |
882873-70-3 |
详细
|
| McMMAF |
MC-MMAF |
863971-19-1 |
详细
|
| DBCO-acid |
DBCO-酸 |
1353016-70-2 |
详细
|
| MAC glucuronide linker-2 |
|
229977-57-5 |
详细
|
| Fmoc-3VVD-OH |
FMOC-3AA-OH |
863971-44-2 |
详细
|
| Boc-Gly-Gly-Phe-Gly-OH |
|
187794-49-6 |
详细
|
| Bi-Mc-VC-PAB-MMAE |
化合物 BI-MC-VC-PAB-MMAE |
1620837-70-8 |
详细
|
| 6-Maleimidohexanoic acid N-hydroxysuccinimide ester |
6-(马来酰亚胺基)己酸琥珀酰亚胺酯 |
55750-63-5 |
详细
|
| MCC-DM1 |
|
1100692-14-5 |
详细
|
| MMAE-SMCC |
|
2021179-11-1 |
详细
|
| Deruxtecan |
德鲁替康 |
1599440-13-7 |
详细
|
| PC Biotin-PEG3-azide |
|
1937270-46-6 |
详细
|
| Ac-Lys-Val-Cit-PABC-MMAE |
化合物 AC-LYS-VAL-CIT-PABC-MMAE |
1650569-89-3 |
详细
|
| BMPS |
3-马来酰亚胺基丙酸羟基琥珀酰亚胺酯 |
55750-62-4 |
详细
|
| SMCC |
4-(N-马来酰亚胺基甲基)环己烷-1-羧酸琥珀酰亚胺酯 |
64987-85-5 |
详细
|
| Vipivotide tetraxetan Ligand-Linker Conjugate |
Vipivotide tetraxetan Linker |
1703768-74-4 |
详细
|
| Fmoc-NH-PEG4-CH2CH2COOH |
5,8,11,14-四氧杂-2-氮杂十七烷二酸 1-(9H-芴-9-基甲基)酯 |
557756-85-1 |
详细
|
| m-PEG2-Amine |
1-(2-氨基乙氧基)-2-甲氧基乙烷 |
31576-51-9 |
详细
|
| Fmoc-NH-PEG3-CH2CH2COOH |
N-芴甲氧羰基-12-氨基-4,7,10-三氧杂十二酸 |
867062-95-1 |
详细
|
| Polatuzumab |
|
2279068-37-8 |
详细
|
| AMPD2 inhibitor 1 |
|
2139356-35-5 |
详细
|
| ABT 702 dihydrochloride |
ABT 702 DIHYDROCHLORIDE(二盐酸盐) |
1188890-28-9 |
详细
|
| LRE1 |
化合物 T15787 |
1252362-53-0 |
详细
|
| TDI-10229 |
|
2810887-45-5 |
详细
|
| Fidarestat |
非达司他 |
136087-85-9 |
详细
|
| Imirestat |
咪瑞司他 |
89391-50-4 |
详细
|
| Caficrestat |
AT-001 |
1355612-71-3 |
详细
|
| Sorbinil |
索比尼尔 |
68367-52-2 |
详细
|
| Repotrectinib |
洛普替尼 |
1802220-02-5 |
详细
|
| ITE |
|
448906-42-1 |
详细
|
| BAY1125976 |
CS-2913 |
1402608-02-9 |
详细
|
| TASP0415914 |
CS-2671 |
1292300-75-4 |
详细
|
| AKT-IN-3 |
|
2374740-21-1 |
详细
|
| Vevorisertib trihydrochloride |
化合物VEVORISERTIB TRIHYDROCHLORIDE |
1416775-08-0 |
详细
|
| (E)-Akt inhibitor-IV |
CS-1992 |
959841-49-7 |
详细
|
| ALM301 |
化合物 ALM301 |
1313439-71-2 |
详细
|
| PI3K/Akt/CREB activator 1 |
化合物 PI3K/AKT/CREB ACTIVATOR 1 |
2708177-73-3 |
详细
|
| Uprosertib |
|
1047634-65-0 |
详细
|
| Akt1/Akt2-IN-1 |
3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮 |
893422-47-4 |
详细
|
| Sincalide ammonium |
SINCALIDE AMMONIUM (CHOLECYSTOKININ OCTAPEPTIDE AMMONIUM) |
70706-98-8 |
详细
|
| NCT-506 |
|
2231098-99-8 |
详细
|
| ALDH1A1-IN-2 |
NCT-507 |
2231081-18-6 |
详细
|
| NCT-501 |
CS-2069 |
1802088-50-1 |
详细
|
| TIP 39, Tuberoinfundibular Neuropeptide |
SER-LEU-ALA-LEU-ALA-ASP-ASP-ALA-ALA-PHE-ARG-GLU-ARG-ALA-ARG-LEU-LEU-ALA-ALA-LEU-GLU-ARG-ARG-HIS-TRP-LEU-ASN-SER-TYR-MET-HIS-LYS-LEU-LEU-VAL-LEU-ASP-ALA-PRO |
277302-47-3 |
详细
|
| Lysipressin acetate |
赖氨加压素醋酸盐 |
83968-49-4 |
详细
|
| Crosstide |
模拟肽CROSSTIDE |
171783-05-4 |
详细
|
| K-80003 |
1292821-90-9 |
1292821-90-9 |
详细
|
| AT-007 |
|
2170729-29-8 |
详细
|
| Azido-PEG4-Val-Cit-PAB-MMAE |
叠氮-四聚乙二醇-VAL-CIT-PAB-MMAE |
1869126-64-6 |
详细
|
| 9-Cyclopentyladenine monomethanesulfonate |
|
189639-09-6 |
详细
|
| Fipexide |
1-(2-[4-氯苯氧基]乙酰基)-4-(3,4-亚甲二氧基苄基)哌嗪 |
34161-24-5 |
详细
|
| Glembatumumab |
格巴妥木单抗 |
1020264-78-1 |
详细
|
| Lidorestat |
利多司他 |
245116-90-9 |
详细
|
| A-674563 |
|
552325-73-2 |
详细
|
| MKC-1 |
化合物MKC-1 |
125313-92-0 |
详细
|
| Ipatasertib |
帕他色替 |
1001264-89-6 |
详细
|
| Miransertib |
ARQ-092 |
1313881-70-7 |
详细
|